Abingworth as of June 30, 2018
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 41.5 | $73M | 1.2M | 58.76 | |
| Sientra | 27.6 | $48M | 2.5M | 19.48 | |
| Paratek Pharmaceuticals | 6.0 | $11M | 1.0M | 10.15 | |
| Obseva Sa | 3.8 | $6.7M | 440k | 15.14 | |
| Gtx Inc Del | 3.0 | $5.2M | 339k | 15.32 | |
| Proteon Therapeutics | 2.8 | $4.8M | 2.0M | 2.40 | |
| Sierra Oncology | 2.4 | $4.3M | 1.4M | 2.96 | |
| Cymabay Therapeutics | 2.1 | $3.7M | 273k | 13.41 | |
| Chiasma | 1.8 | $3.1M | 2.1M | 1.50 | |
| Adaptimmune Therapeutics (ADAP) | 1.7 | $3.0M | 250k | 11.86 | |
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $2.9M | 38k | 76.85 | |
| Cellectis S A (CLLS) | 1.6 | $2.8M | 100k | 28.25 | |
| Aurinia Pharmaceuticals (AUPH) | 1.3 | $2.3M | 400k | 5.62 | |
| Histogenics Corp Cmn | 1.3 | $2.2M | 889k | 2.48 | |
| Immune Design | 0.9 | $1.6M | 352k | 4.60 | |
| AVEO Pharmaceuticals | 0.5 | $900k | 400k | 2.25 |
